Clinical strategy for the diagnosis and treatment of dystonia / 中华神经科杂志

ABSTRACT

Dystonia is a highly heterogeneous disorder both in clinical and genetical manifestation. It is sometimes associated with poor outcomes in clinical practice. Understanding of the definition, classification, mechanism of dystonia is helpful for optimizing management and improving the implementation. Genetic testing for dystonia is important as an accurate molecular diagnosis in certain genes which can influence therapeutic decisions. Referring to the current situation of clinical practice and expert views in China, this article shares the principles of clinical diagnosis and treatment and the application of gene testing, hoping to provide reference to the diagnosis and treatment decisions of dystonia for the ordinary neurologists in the process of medical practice.